This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.

Launch Date: May 2, 2024

Release Date: May 2, 2024

Expiration Date: April 30, 2025

FACULTY BIO

Jesús G. Berdeja, MD

Director of Multiple Myeloma Research

The Greco-Hainsworth Tennessee Oncology Centers for Research

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Chief Medical Officer, International Myeloma Foundation

Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, Honor

Health Research Institute

Adjunct Professor, College of Health Solutions, Arizona State University

Saad Usmani, MD

Chief, Myeloma Service

Memorial Sloan Kettering Cancer Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.

Launch Date: May 2, 2024

Release Date: May 2, 2024

Expiration Date: April 30, 2025

FACULTY BIO

Jesús G. Berdeja, MD

Director of Multiple Myeloma Research

The Greco-Hainsworth Tennessee Oncology Centers for Research

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Chief Medical Officer, International Myeloma Foundation

Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, Honor

Health Research Institute

Adjunct Professor, College of Health Solutions, Arizona State University

Saad Usmani, MD

Chief, Myeloma Service

Memorial Sloan Kettering Cancer Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.

Launch Date: May 2, 2024

Release Date: May 2, 2024

Expiration Date: April 30, 2025

FACULTY BIO

Jesús G. Berdeja, MD

Director of Multiple Myeloma Research

The Greco-Hainsworth Tennessee Oncology Centers for Research

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Chief Medical Officer, International Myeloma Foundation

Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, Honor

Health Research Institute

Adjunct Professor, College of Health Solutions, Arizona State University

Saad Usmani, MD

Chief, Myeloma Service

Memorial Sloan Kettering Cancer Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conversations-in-relapsedrefractory-multiple-myeloma-strategies-to-effectively-introduce-optimize-and-sequence-bispecific-antibody-therapy-8

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Gilles Salles, MD, and Matthew Lunning, MD, identify and integrate crucial advances in follicular lymphoma presented at the 2023 American Society of Hematology (ASH) annual conference.

Launch Date: February 1, 2024

Release Date: February 1, 2024

Expiration Date: January 31, 2025

FACULTY BIOS

Gilles Salles, MDChief, Lymphoma ServiceMemorial Sloan Kettering Cancer CenterMatthew Lunning, DOAssociate Professor of Hematology/OncologyUniversity of Nebraska Medical Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conversations-in-hematologyoncology-incorporating-key-updates-in-the-treatment-of-follicular-lymphoma-a-discussion-following-ash-2023-on-assimilating-practice-changing-breakthroughs-14

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Gilles Salles, MD, and Matthew Lunning, MD, identify and integrate crucial advances in follicular lymphoma presented at the 2023 American Society of Hematology (ASH) annual conference.

Launch Date: February 1, 2024

Release Date: February 1, 2024

Expiration Date: January 31, 2025

FACULTY BIOS

Gilles Salles, MDChief, Lymphoma ServiceMemorial Sloan Kettering Cancer CenterMatthew Lunning, DOAssociate Professor of Hematology/OncologyUniversity of Nebraska Medical Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conversations-in-hematologyoncology-incorporating-key-updates-in-the-treatment-of-follicular-lymphoma-a-discussion-following-ash-2023-on-assimilating-practice-changing-breakthroughs-14

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Gilles Salles, MD, and Matthew Lunning, MD, identify and integrate crucial advances in follicular lymphoma presented at the 2023 American Society of Hematology (ASH) annual conference.

Launch Date: February 1, 2024

Release Date: February 1, 2024

Expiration Date: January 31, 2025

FACULTY BIOS

Gilles Salles, MDChief, Lymphoma ServiceMemorial Sloan Kettering Cancer CenterMatthew Lunning, DOAssociate Professor of Hematology/OncologyUniversity of Nebraska Medical Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conversations-in-hematologyoncology-incorporating-key-updates-in-the-treatment-of-follicular-lymphoma-a-discussion-following-ash-2023-on-assimilating-practice-changing-breakthroughs-14

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).

Launch Date: January 29, 2024

Release Date: January 29, 2024

Expiration Date: December 30, 2024

FACULTY BIOS

Prithviraj Bose, MD

Professor, Department of Leukemia, Division of Cancer Medicine

University of Texas

MD Anderson Cancer Center

John Mascarenhas, MD

Professor of Medicine

Icahn School of Medicine at Mount Sinai

Director, Center of Excellence in Blood Cancers and Myeloid Disorders

Ruben Mesa, MD

Executive Director

Atrium Health Wake Forest Baptist Comprehensive Cancer Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).

Launch Date: January 29, 2024

Release Date: January 29, 2024

Expiration Date: December 30, 2024

FACULTY BIOS

Prithviraj Bose, MD

Professor, Department of Leukemia, Division of Cancer Medicine

University of Texas

MD Anderson Cancer Center

John Mascarenhas, MD

Professor of Medicine

Icahn School of Medicine at Mount Sinai

Director, Center of Excellence in Blood Cancers and Myeloid Disorders

Ruben Mesa, MD

Executive Director

Atrium Health Wake Forest Baptist Comprehensive Cancer Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).

Launch Date: January 29, 2024

Release Date: January 29, 2024

Expiration Date: December 30, 2024

FACULTY BIOS

Prithviraj Bose, MD

Professor, Department of Leukemia, Division of Cancer Medicine

University of Texas

MD Anderson Cancer Center

John Mascarenhas, MD

Professor of Medicine

Icahn School of Medicine at Mount Sinai

Director, Center of Excellence in Blood Cancers and Myeloid Disorders

Ruben Mesa, MD

Executive Director

Atrium Health Wake Forest Baptist Comprehensive Cancer Center

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17

This is an accredited continuing education series of four (4) podcasts as downloadable audio files (MP3). In these dynamic and interactive podcast sessions, Dr. James Bussel and Dr. Cindy Neunert discuss emerging evidence for management strategies for ITP, including utilization of patient reported outcomes and shared decision making to improve outcomes. Two case presentations will be discussed to help clinicians select the most appropriate treatment as well as incorporate patient reported outcomes and shared decision making into their routine clinical practice.

Launch Date: December 28, 2023

Release Date: December 28, 2023

Expiration Date: November 30, 2024

FACULTY BIOS

James Bussel, MD

Professor Emeritus

Pediatric Hematology-Oncology

Weill Cornell Medicine New York

New York, NY

Cindy Neunert, MD

Division of Pediatric Hematology

Oncology, and Stem Cell Transplantation

Columbia University Irving Medical Center

New York, NY

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/expert-insights-on-itp-how-do-emerging-treatment-strategies-have-the-potential-to-transform-patient-outcomes-39